Etbaigha F, R Willms A, Poljak Z. An SEIR model of influenza A virus infection and reinfection within a farrow-to-finish swine farm. PLoS One. 2018 Sep 24;. Abstract
submitted by kickingbird at Sep, 28, 2018 from PLoS One. 2018 Sep 24; (via https://journals.plos.org/plosone/article?id=10.1371/journal)
Influenza A virus (IAV) in swine is a pathogen that causes a threat to the health as well as to the production of swine. Moreover, swine can spread this virus to other species including humans. The virus ... O?Bryant SC1, Lewis JD, Cruz AT, Mothner BA.. Influenza A-Associated Epiglottitis and Compensatory Pursed Lip Breathing in an Infant. Pediatr Emerg Care. 2018 Sep 21. Abstract
submitted by kickingbird at Sep, 28, 2018 from Pediatr Emerg Care. 2018 Sep 21 (via https://journals.lww.com/pec-online/Abstract/publishahead/In)
The last 3 decades have seen a shift in the epidemiology of epiglottitis. Epiglottitis was once most commonly associated with Haemophilus influenzae type B. However, with the implementation of the H. influenzae ... Kiseleva I, etc.,al. Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets. Biomed Res Int. 2018 Aug 30. Abstract
submitted by kickingbird at Sep, 28, 2018 from Biomed Res Int. 2018 Aug 30 (via https://www.hindawi.com/journals/bmri/2018/9695628/)
Background: Currently, two genetic lineages of influenza B virus, B/Victoria and B/Yamagata, are cocirculating in humans in various countries. This situation has raised a question regarding the possibility ... Koul P, Potdar V, Mir H, Chadha M. The 2015 Outbreak of Severe Influenza in Kashmir, North India: Emergence of a New Clade of A/H1n1 Influenza Virus. PLoS Curr. 2018 Aug 8. Abstract
submitted by kickingbird at Sep, 28, 2018 from PLoS Curr. 2018 Aug 8 (via https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122875/)
INTRODUCTION: Following the initial outbreak of A/H1N1pdm09, periodic resurgences of the virus, with variable morbidity and mortality, have been reported from various parts of India including the temperate ... Roto D, Malnoske ML, Winters S, Georas SN. A Fatal Case of Influenza B Myocarditis with Cardiac Tamponade. Case Rep Crit Care. 2018 Aug 30;2018:8026314.. Abstract
submitted by kickingbird at Sep, 28, 2018 from Case Rep Crit Care. 2018 Aug 30;2018:8026314. (via https://www.ncbi.nlm.nih.gov/pubmed/30245893)
Background: Influenza B is generally regarded as a less severe counterpart to influenza A, typically causing mild upper respiratory symptoms. Myocardial involvement with influenza B is a rare complication, ... Kanyiri CW, Mark K, Luboobi L. Mathematical Analysis of Influenza A Dynamics in the Emergence of Drug Resistance. Comput Math Methods Med. 2018 Aug 29;2018:2434560.. Abstract
submitted by kickingbird at Sep, 28, 2018 from Comput Math Methods Med. 2018 Aug 29;2018:2434560. (via https://www.ncbi.nlm.nih.gov/pubmed/30245737)
Every year, influenza causes high morbidity and mortality especially among the immunocompromised persons worldwide. The emergence of drug resistance has been a major challenge in curbing the spread of ... Momose H, etc.,al. Gene expression profiling toward the next generation safety control of influenza vaccines and adjuvants in Japan. Vaccine. 2018 Sep 19.. Abstract
submitted by kickingbird at Sep, 28, 2018 from Vaccine. 2018 Sep 19. (via https://www.ncbi.nlm.nih.gov/pubmed/30243500)
Influenza becomes epidemic worldwide every year, and many individuals receive vaccination annually. Quality control relating to safety and potency of influenza vaccines is important to maintain public ... Konstantinos Voskarides, Eirini Christaki, etc.,al. Influenza Virus-Host Co-evolution. A Predator-Prey Relationship?. Front Immunol. 2018; 9: 2017. Abstract
submitted by kickingbird at Sep, 28, 2018 from Front Immunol. 2018; 9: 2017 (via https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6137132/)
Influenza virus continues to cause yearly seasonal epidemics worldwide and periodically pandemics. Although influenza virus infection and its epidemiology have been extensively studied, a new pandemic ... Yan LM, etc.,al. Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection. Virology. 2018 Sep 21;525:73-82. Abstract
submitted by kickingbird at Sep, 28, 2018 from Virology. 2018 Sep 21;525:73-82 (via https://www.ncbi.nlm.nih.gov/pubmed/30248524)
The limited protection of current commerical vaccines necessitates the investigation of novel vaccine strategies for unpredictable outbreaks. To investigate the feasibility of using vaccines derived from ... Thapa B. etc., al. The Burden of Influenza‐Associated Respiratory Hospitalizations in Bhutan, 2015~2016. Influenza Other Respir Viruses. 2018 Aug 23.. Abstract
submitted by kickingbird at Sep, 27, 2018 from Influenza Other Respir Viruses. 2018 Aug 23. (via https://onlinelibrary.wiley.com/doi/abs/10.1111/irv.12605)
BackgroundInfluenza burden estimates help provide evidence to support influenza prevention and control programs. In this study, we estimated influenza‐associated respiratory hospitalization rates in Bhutan, ... Cheng X. etc., al.. Using an innovative method to develop the threshold of seasonal influenza epidemic in China. PLoS One. 2018 Aug 31;13(8):e0202880.. Abstract
submitted by kickingbird at Sep, 27, 2018 from PLoS One. 2018 Aug 31;13(8):e0202880. (via https://journals.plos.org/plosone/article?id=10.1371/journal)
BackgroundProper early warning thresholds for defining seasonal influenza epidemics are crucial for timely engagement of intervention strategies, but are currently not well established in China. We propose ... Cheng Q, Zhao G, Xie L, Wang X. Impacts of age and gender at the risk of underlying medical conditions and death in patients with avian influenza A (H7N9): a meta-analysis study. Ther Clin Risk Manag. 2018 Sep 6. Abstract
submitted by kickingbird at Sep, 26, 2018 from Ther Clin Risk Manag. 2018 Sep 6 (via https://www.ncbi.nlm.nih.gov/pubmed/30233197)
Objective: The objective of our study was to conduct a series of analyses that examined the impacts of age and gender at the risk of underlying medical conditions (UMCs) and death in patients with influenza ... Ferraris O, etc.,al. The NS Segment of H1N1pdm09 Enhances H5N1 Pathogenicity in a Mouse Model of Influenza Virus Infections. Viruses. 2018 Sep 17. Abstract
submitted by kickingbird at Sep, 26, 2018 from Viruses. 2018 Sep 17 (via https://www.ncbi.nlm.nih.gov/pubmed/30227598)
In 2009, the co-circulation of H5N1 and H1N1pdm09 raised concerns that a reassortment event may lead to highly pathogenic influenza strains. H1N1pdm09 and H5N1 are able to infect the same target cells ... Pereira CF, etc.,al. Effects of mutations in the effector domain of influenza A virus NS1 protein. BMC Res Notes. 2018 Sep 18. Abstract
submitted by kickingbird at Sep, 26, 2018 from BMC Res Notes. 2018 Sep 18 (via https://www.ncbi.nlm.nih.gov/pubmed/30227889)
OBJECTIVE: The multifunctional NS1 protein of influenza A virus has roles in antagonising cellular innate immune responses and promoting viral gene expression. To better understand the interplay between ... Tan M, etc.,al. Saliva as a source of reagent to study human susceptibility to avian influenza H7N9 virus infection. Emerg Microbes Infect. 2018 Sep 19. Abstract
submitted by kickingbird at Sep, 26, 2018 from Emerg Microbes Infect. 2018 Sep 19 (via https://www.ncbi.nlm.nih.gov/pubmed/30228261)
Avian influenza H7N9 viruses are an important public health concern due to their high mortality rate and potentials for future pandemics. We investigated human susceptibility to H7N9 viruses using recombinant ... Yan J, Guha S, Hariharan P, Myers M. Modeling the Effectiveness of Respiratory Protective Devices in Reducing Influenza Outbreak. Risk Anal. 2018 Sep 19. Abstract
submitted by kickingbird at Sep, 26, 2018 from Risk Anal. 2018 Sep 19 (via https://www.ncbi.nlm.nih.gov/pubmed/30229968)
Outbreaks of influenza represent an important health concern worldwide. In many cases, vaccines are only partially successful in reducing the infection rate, and respiratory protective devices (RPDs) are ... Thompson CP, etc.,al. A naturally protective epitope of limited variability as an influenza vaccine target. Nat Commun. 2018 Sep 21;9(1):3859. Abstract
submitted by kickingbird at Sep, 26, 2018 from Nat Commun. 2018 Sep 21;9(1):3859 (via https://www.ncbi.nlm.nih.gov/pubmed/30242149)
Current antigenic targets for influenza vaccine development are either highly immunogenic epitopes of high variability or conserved epitopes of low immunogenicity. This requires continuous update of the ... Gordon A, Tsang TK, Cowling BJ, Kuan G, Ojeda S, S. Influenza Transmission Dynamics in Urban Households, Managua, Nicaragua, 2012~2014. Emerg Infect Dis. 2018 Oct;24(10):1882-1888.. Abstract
submitted by kickingbird at Sep, 26, 2018 from Emerg Infect Dis. 2018 Oct;24(10):1882-1888. (via https://www.ncbi.nlm.nih.gov/pubmed/30226161)
During August 2012-November 2014, we conducted a case ascertainment study to investigate household transmission of influenza virus in Managua, Nicaragua. We collected up to 5 respiratory swab samples from ... Lee DH, Torchetti MK, Hicks J, Killian ML, Bahl J,. Transmission Dynamics of Highly Pathogenic Avian Influenza Virus A(H5Nx) Clade 2.3.4.4, North America, 2014~2015. Emerg Infect Dis. 2018 Oct;24(10):1840-1848.. Abstract
submitted by kickingbird at Sep, 26, 2018 from Emerg Infect Dis. 2018 Oct;24(10):1840-1848. (via https://www.ncbi.nlm.nih.gov/pubmed/30226167)
Eurasia highly pathogenic avian influenza virus (HPAIV) H5 clade 2.3.4.4 emerged in North America at the end of 2014 and caused outbreaks affecting >50 million poultry in the United States before eradication ... Diallo A, etc.,al. Immunogenicity and safety of MF59-adjuvanted and full-dose unadjuvanted trivalent inactivated influenza vaccines among vaccine-na?ve children in a randomized clinical trial in rural Senegal. Vaccine. 2018 Sep 14.. Abstract
submitted by kickingbird at Sep, 26, 2018 from Vaccine. 2018 Sep 14. (via https://www.ncbi.nlm.nih.gov/pubmed/30224199)
INTRODUCTION: Effective, programmatically suitable influenza vaccines are needed for low-resource countries.MATERIALS AND METHODS: This phase II, placebo-controlled, randomized safety and immunogenicity ... 7583 items, 20/Page, Page[193/380][|<<] [|<] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [>|] [>>|] |
Related Pages:
Browse by Category
Learn about the flu news, articles, events and more
Subscribe to the weekly F.I.C newsletter!
|
- 
